Trials / Unknown
UnknownNCT02856399
Long-term Effects of Methadone for Cancer Pain
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The methadone is an useful opioid for the cancer pain treatment, mostly used in second or last line during the opioid rotation. The Methadone had an anti-MNDA effect, and clinicians agree that the methadone could have an effect in neuropathic cancer pain. During a previous study the investigators find that the pain was still improving after the week 2, but they had only a small number of patients still included at this stage and they cannot conclude. The investigators decide to follow up systematically all the patients undergoing a methadone treatment for cancer pain, at day 28, to study the hypothesis about the long-term pain improvement.
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2016-08-04
- Last updated
- 2016-08-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02856399. Inclusion in this directory is not an endorsement.